• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名微血管性冠状动脉疾病患者经心肌激光血运重建术后心肌灌注改善。

Improved myocardial perfusion after transmyocardial laser revascularization in a patient with microvascular coronary artery disease.

作者信息

Oskui Peyman Mesbah, Mayeda Guy S, Burstein Steven, Gheissari Ali, French William J, Thomas Joseph, Kloner Robert A

机构信息

Department of Cardiology, Harbor-UCLA Medical Center, Torrance, CA, USA; Heart Institute, Good Samaritan Hospital, Los Angeles, CA, USA.

Heart Institute, Good Samaritan Hospital, Los Angeles, CA, USA; Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

SAGE Open Med Case Rep. 2014 Mar 4;2:2050313X14526873. doi: 10.1177/2050313X14526873. eCollection 2014.

DOI:10.1177/2050313X14526873
PMID:27489642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4857340/
Abstract

We report the case of a 59-year-old woman who presented with symptoms of angina that was refractory to medical management. Although her cardiac catheterization revealed microvascular coronary artery disease, her symptoms were refractory to optimal medical management that included ranolazine. After undergoing transmyocardial revascularization, her myocardial ischemia completely resolved and her symptoms dramatically improved. This case suggests that combination of ranolazine and transmyocardial revascularization can be applied to patients with microvascular coronary artery disease.

摘要

我们报告了一例59岁女性患者，其心绞痛症状对药物治疗无效。尽管她的心脏导管检查显示为微血管性冠状动脉疾病，但她的症状对包括雷诺嗪在内的最佳药物治疗仍无反应。在接受经心肌血管重建术后，她的心肌缺血完全缓解，症状显著改善。该病例提示，雷诺嗪与经心肌血管重建术联合应用可用于微血管性冠状动脉疾病患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/01a6c00cbfe0/10.1177_2050313X14526873-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/27295c35bd9f/10.1177_2050313X14526873-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/173abc0a4b59/10.1177_2050313X14526873-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/740db71fc3d7/10.1177_2050313X14526873-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/bdef27449c6f/10.1177_2050313X14526873-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/01a6c00cbfe0/10.1177_2050313X14526873-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/27295c35bd9f/10.1177_2050313X14526873-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/173abc0a4b59/10.1177_2050313X14526873-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/740db71fc3d7/10.1177_2050313X14526873-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/bdef27449c6f/10.1177_2050313X14526873-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f414/4857340/01a6c00cbfe0/10.1177_2050313X14526873-fig5.jpg

相似文献

1
Improved myocardial perfusion after transmyocardial laser revascularization in a patient with microvascular coronary artery disease.一名微血管性冠状动脉疾病患者经心肌激光血运重建术后心肌灌注改善。
SAGE Open Med Case Rep. 2014 Mar 4;2:2050313X14526873. doi: 10.1177/2050313X14526873. eCollection 2014.
2
Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.终末期冠状动脉疾病患者使用二氧化碳激光进行心肌血运重建术。
N Engl J Med. 1999 Sep 30;341(14):1021-8. doi: 10.1056/NEJM199909303411402.
3
Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.顽固性心绞痛患者经心肌血运重建术与药物治疗的比较。
N Engl J Med. 1999 Sep 30;341(14):1029-36. doi: 10.1056/NEJM199909303411403.
4
Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up [ssee comments].非再血管化冠状动脉疾病经皮激光心肌血运重建术后3年随访结果[见评论]
Eur Heart J. 1998 Oct;19(10):1525-30. doi: 10.1053/euhj.1998.1152.
5
Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease.经心肌激光血运重建术：一项多中心试验的结果，该试验将经心肌激光血运重建术用作终末期冠状动脉疾病的唯一治疗方法。
J Thorac Cardiovasc Surg. 1997 Apr;113(4):645-53; discussion 653-4. doi: 10.1016/S0022-5223(97)70221-6.
6
[Transmyocardial laser revascularization: a past or future treatment method? (review of the literature)].经心肌激光血运重建术：一种过去的还是未来的治疗方法？（文献综述）
Medicina (Kaunas). 2002;38(6):585-91.
7
Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanidine scintigraphy in the assessment of transmyocardial laser revascularization.
J Thorac Cardiovasc Surg. 2003 Jun;125(6):1493-8. doi: 10.1016/s0022-5223(02)73271-6.
8
Survival after transmyocardial laser revascularization in relation to nonlasered perfused myocardial zones.经心肌激光血运重建术后的生存率与未激光灌注心肌区域的关系。
Ann Thorac Surg. 2001 Feb;71(2):532-6. doi: 10.1016/s0003-4975(00)02457-7.
9
Transmyocardial laser as an adjunct to minimally invasive CABG for complete myocardial revascularization.经心肌激光作为微创冠状动脉旁路移植术实现完全心肌血运重建的辅助手段。
Ann Thorac Surg. 1998 Sep;66(3):1113-8. doi: 10.1016/s0003-4975(98)00711-5.
10
Refractory angina despite patent coronary artery bypass grafts: treatment with transmyocardial laser revascularization and scintigraphic evidence of improved myocardial perfusion.
G Ital Cardiol. 1999 Jan;29(1):72-5.

本文引用的文献

1
Transmyocardial laser revascularization: a meta-analysis and systematic review of controlled trials.经心肌激光血运重建术：对照试验的荟萃分析与系统评价
Innovations (Phila). 2006 Winter;1(6):295-313. doi: 10.1097/IMI.0b013e31802fe0a2.
2
A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions.
J Am Coll Cardiol. 2002 May 15;39(10):1581-7. doi: 10.1016/s0735-1097(02)01829-6.
3
Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.顽固性心绞痛患者经心肌血运重建术与药物治疗的比较。
N Engl J Med. 1999 Sep 30;341(14):1029-36. doi: 10.1056/NEJM199909303411403.
4
Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.
Lancet. 1999 Sep 11;354(9182):885-90. doi: 10.1016/s0140-6736(99)08113-1.
5
Transmyocardial laser revascularization does not denervate the canine heart.经心肌激光血运重建术不会使犬心去神经支配。
Ann Thorac Surg. 1999 Aug;68(2):460-8; discussion 468-9. doi: 10.1016/s0003-4975(99)00558-5.
6
Holmium:YAG laser transmyocardial revascularization relieves angina and improves functional status.钬激光心肌血运重建术可缓解心绞痛并改善功能状态。
Ann Thorac Surg. 1999 Jun;67(6):1596-601; discussion 1601-2. doi: 10.1016/s0003-4975(99)00368-9.
7
Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial.
Lancet. 1999 Feb 13;353(9152):519-24. doi: 10.1016/s0140-6736(98)11478-2.
8
Transmyocardial laser treatment denervates canine myocardium.经心肌激光治疗使犬心肌去神经支配。
J Thorac Cardiovasc Surg. 1997 Dec;114(6):883-9; discussion 889-90. doi: 10.1016/S0022-5223(97)70001-1.
9
Transmyocardial laser revascularization. Histological features in human nonresponder myocardium.经心肌激光血运重建术。人类无反应心肌的组织学特征。
Circulation. 1997 Jan 21;95(2):371-5. doi: 10.1161/01.cir.95.2.371.
10
A histologic study of laser-induced transmyocardial channels.激光诱导心肌通道的组织学研究。
Lasers Surg Med. 1987;6(6):563-73. doi: 10.1002/lsm.1900060617.